SRC:MixSentence, IDs:DE757C7F;BACBF0FD;59BFF157;99219F16;3AD5669B;1A2158AA;E73F66B8;1CB5D976;4D53DCA5;79DC2939;07405E10;D9DF529F;953A87C9;24F2A662;F42FD8B5;FA6D331A;AD2F6436;5B7C9030;3F3E5ECC;CEC0943E;B7B2D198;2C5C1CED;62457DA4;A104E536;B18379B1;1BB88423;0ECB4049;CC2BCDF5;5AD61E1B;5E804A06;4AFB1C5A;42D3ECC2;F3096291;DDF36E88;97FF2358;46DCC845;3EEB98CB;6C181902;AF24C528;6D9ED704;878FED22;4F03F29E;04EFBA12;938DDB5B;AAAAE8D1;65591CD5

Given the evolving landscape of taxation and fixed asset treatment rules, especially in the face of increased legislative environments across global boundaries, each with its unique demands, a focus on reduced risks can help build stronger ties and client loyalty. Law firms need a partner to help with the management of their online marketing. When a user visits your Tiemann Law Firm website, they don’t need to struggle with the webpage content that isn’t mobile-friendly. There’s no better way to capitalize on this than to give your readers free tips and advice related to that area of exceptional expertise. Our goal is to explore ways to remove that harm, and to find a better way to achieve the same result with less harm done. Book a free 30-minute strategy call and let's look at exactly where your firm is, where you want it to go, and what's standing in the way. Use an email optin on restaurant website, online ordering and loyalty rewards program to grow your email database. Feel free to get creative and test out multiple Primary Texts and Headlines to see what resonates best with your audience. I see companies where management increasingly defines success as more agents, the more the better.

ewebe.huSRC:MixSentence, IDs:4F45A2FE;8E020393;430C4AF5;D7418648;029700BB;3AD5669B;CEC0943E;5E804A06;2C342F27;6B520626;EA73E075;F7F7F036;167CCA31;FEE5A7E4;AF24C528;07405E10;FDCAA27E;F1FE3AF6;F4EC029B;CC2BCDF5;49E5C53D;CE505E59;A29C6F39;103B5D06;878FED22;63624C40;03D22A85

"The time it takes for a new technology to be adopted by 50 percent of US households has long been used by economic historians for cross-technology comparisons. "But, of course, inferences can be made." One such "potential theoretical conclusion" of the article, Ms. "Obviously, we have to stick within data limits of what's published currently as well as what we know are factual about these products," he told the doctors. Zabusky added, was that a drug that worked for 9 hours might be better than a 12-hour drug. A study expected to provide scientific data showing Ritalin LA's advantages was not scheduled to start until the following day, he said, but the lack of research findings should not be an obstacle. Markowitz and Kennerly S. To produce the new draft, Intramed turned to Linda Logdberg, who has a doctorate in anatomy and has made her living the last 12 years as a ghostwriter for Intramed and other medical marketing companies. We would like to help draft this manuscript," Marcia Zabusky, a vice president of Intramed, told the doctors in a conference call, according to a transcript of the conversation obtained by The New York Times, "and then submit it to you for your - for your editing and for approval." During the call, Shane Schaffer, a Novartis marketing executive, told the doctors that the company wanted "a quick, down and dirty" article. Patrick said as the call concluded. "I think we're quite clear on what you want the next manuscript to look like," Dr. Logdberg, who recently took a job teaching biology to high school students, said that she had become increasingly disenchanted with the process. Typically, she said, her manuscript would be sent to the drug company for approval before it was given to the doctors who were paid to be listed as the authors. The assignment was one of her last ghostwriting tasks. Logdberg said that she produced a new manuscript in a few days. Some doctors fretted over each comma, Dr. Patrick of the Medical University of South Carolina - agreed to what Intramed and Novartis proposed. "What I mind is advertising that calls itself education." The ad agencies' medical education companies say that they neither toy with science nor ghostwrite articles that physicians use to make decisions about prescribing drugs. Logdberg said, is marketing masquerading as science. "We make editorial suggestions," said Jed A. Starting with an outline approved by Intramed, Dr. Patrick agreed, saying that Intramed did not dictate what their paper should say. Beitler, chairman of Sudler & Hennessey, a division at WPP that includes Intramed. Logdberg said, while others made no changes at all. "No figure, no table, anything goes in without our approval," Dr. "The doctors are the ultimate writers." Dr. The marketing companies, she added, "will drop a doctor if they don't think he will be particularly malleable." The result, Dr. Patrick added that he thought, based on past research, that a drug like Ritalin LA could be better for certain children than other long-lasting drugs. If you adored this post and you would certainly such as to receive more facts relating to help article kindly browse through the web-site. Instead, the company said, it was a review of the available medications in which the authors could suggest theoretical advantages. Logdberg produced and later gave the assignment to another writer. Beitler said that Intramed was unhappy with the manuscript that Dr. The article has not been published. Some experts think the practice continues to grow, even as the best journals take steps to prevent it. A 1998 survey of named authors writing for some of the nation's top journals, including The Journal of the American Medical Association, which published the survey, found that 11 percent of the articles had been ghostwritten. One document made public in a whistle-blower lawsuit against Warner-Lambert describes how Proworx, a company owned by the ad giant Omnicom, offered to help write journal articles about using Neurontin to treat pain. Wyeth hired ghostwriters in promoting the diet drug combination fen-phen, according to documents made public in litigation filed after it became evident that fen-phen caused a potentially deadly heart-valve defect. Neither the doctors nor the companies disputed the accuracy of the transcript of their conference call. Omnicom declined to comment on the matter. "We don't get anywhere in medicine without objective data," he said. Novartis said the article was not intended to conclude that one product was better than the others. Evidence of ghostwriting has also surfaced in federal and state investigations of Warner-Lambert's marketing of Neurontin, an epilepsy drug, for more than a dozen unapproved uses. Relman, the former editor of The New England Journal of Medicine, said there was no place in medical education for ad agencies. "That's the coin of the realm. Proworx planned to recruit doctors to be the named authors of the articles, paying them a $1,500 fee.